Latin America Infusion Pump Market worth US$1.00 billion by 2030 with 6.2% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 16, 2025 /PRNewswire/ -- The global Latin America Infusion Pump Market, valued at US$0.70 billion in 2024, stood at US$ 0.74 billion in 2025 and is projected to advance at a resilient CAGR of 6.2% from 2025 to 2030, culminating in a forecasted valuation of US$1.00 billion by the end of the period. The Latin America infusion pumps market is growing rapidly due to increasing healthcare awareness and improved access to advanced medical technologies across the region. Rising investments in healthcare infrastructure, especially in rural and underserved areas, are boosting the adoption of infusion pumps. Additionally, the growing demand for minimally invasive treatment options and the rising prevalence of infectious diseases that require intravenous therapies are key contributors. The expansion of home healthcare services and the preference for personalized medicine are additional growth factors for the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210275733

Browse in-depth TOC on "Latin America Infusion Pump Market"

259 - Tables
60 - Figures
297 - Pages

By product, the market is segmented into accessories & consumables and devices. Several interrelated factors propel the consumption of consumables & accessories in the market. The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders necessitates continuous and precise medication delivery, thereby driving demand for compatible accessories like IV sets, catheters, and tubing. Advancements in infusion pump technology, including smart pumps with real-time monitoring and wireless connectivity, have heightened the need for specialized consumables that ensure optimal performance and patient safety.

By type, the accessories & consumables market is segmented into dedicated and non-dedicated accessories & consumables. The dedicated accessories & consumables segment is expected to dominate the market during the forecast period, owing to the requirement of compatible administration sets by manufacturers that are designed for a specific type of infusion pump for optimal results.

By devices Type, the devices market is segmented into stationary and portable infusion pumps. The portable infusion pumps segment is expected to grow at a higher CAGR owing to rising technological advancements in infusion pump devices and the increasing adoption of insulin & ambulatory infusion pumps in home care settings.

By application, the chemotherapy/oncology application segment is expected to dominate the market during the forecast period. The factors contributing to market growth include the rising incidence of cancer, the growing availability of ambulatory infusion pumps for chemotherapy, and the introduction of technologically advanced products.

By geography, The LATAM infusion pumps market is segmented into Brazil, Mexico, Argentina, Colombia, Chile, Ecuador, Peru, and the rest of Latin America. Colombia is expected to register the highest growth because of a rising burden of chronic diseases that require controlled drug delivery, such as diabetes and cancer, which increases demand for hospital and home infusions. Ongoing upgrades to hospitals and clinics and higher health spending make it easier to buy smart, interoperable pumps and related software. Home care and outpatient treatment growth is also expected to boost the need for portable & insulin pumps as services expand beyond hospitals.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=210275733

The key players in the LATAM infusion pumps market are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), Medtronic plc (Ireland), ICU Medical, Inc. (US), Terumo Corporation (Japan), Nipro Corporation (Japan), Avanos Medical, Inc. (US), JMS Co., Ltd. (Japan), Cardinal Health, Inc. (US), Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Ypsomed Holding AG (Switzerland), and Tandem Diabetes Care, Inc. (US), among others.

B. Braun Melsungen AG (Germany):

B. Braun Melsungen AG is a global healthcare provider specializing in medical products for anesthesia, cardiology, intensive care, surgery, extracorporeal treatments, and home care. The company operates across four central business units—Hospital Care, Aesculap, Avitum, and Outpatient markets—offering infusion, nutrition, and pain therapy solutions. With operations in about 64 countries and 262 consolidated companies, B. Braun has leading manufacturing sites in regions including Germany, Brazil, China, India, and the US. Its subsidiaries include B. Braun Surgical GmbH (Germany), B. Braun Medical A/S (Denmark), and B. Braun Medical S.A. (Spain). In 2020, the firm employed over 64,000 people globally, serving hospitals, clinics, and private practitioners.

For more information, Inquire Now!

Related Reports:

Infusion Pump Market

Top 10 Medical Device Technologies Market

Insulin Delivery Devices Market

Pain Management Devices Market

IoT Medical Devices Market                       

Get access to the latest updates on Latin America Infusion Pump Companies and Latin America Infusion Pump Market Size

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

SOURCE MarketsandMarkets